日本の健康な被験者を対象としたデング熱4価ワクチン（TDV）の研究

基本情報

NCT ID

NCT06741683

ステータス

完了

試験のフェーズ

第2/第3相

試験タイプ

介入

目標被験者数

187

治験依頼者名

Takeda

概要

Dengue fever is caused by an infection with the dengue virus. Vaccination with TDV can help prevent dengue fever. The main purpose of this study is to learn about TDV's ability to create an immune response in adults, adolescents, and children administered. In this study, participants will receive 2 vaccinations with TDV (the second 3 months after the first). During the study, participants will visit their study clinic 5 times. Participants will be in this study for approximately 270 days (9 months).

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)